11 May 2020
Cannabis-based consumer products are currently enjoying a huge surge in popularity across Europe. The best sellers are food items, food supplements and cosmetics. There has also been increased demand for medicinal cannabis since it was legalised in a number of EU countries in 2017, and particularly with it now being covered by health insurance policies in some cases. Finished medicinal products, and magistral as well as officinal formulas, are also a key part of this trend. There are, however, a number of issues relating to the marketing of cannabis products which still need to be clarified. One of the key issues is the extent to which foods containing cannabidiol should be classified as "novel food". This Client Briefing is designed to provide an overview of the legal framework and requirements for offering and marketing medicinal cannabis products and cannabis-based consumer goods.